Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria

Leukemia Research

Volumn 37, Issue 4, 2013, Pages 401-409

  Shao, Haipeng ^c   Calvo, Katherine R ^b   Grönborg, Marlene ^a   Tembhare, Prashant R ^a   Kreitman, Robert J ^a   Stetler Stevenson, Maryalice ^a   Yuan, Constance M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Flow cytometry; Hairy cell leukemia; Hairy cell leukemia variant; Immunophenotype, HCL, HCL v, CD11c, CD25, CD103, CD123

Indexed keywords

ANTIGEN; B RAF KINASE; CD013 ANTIGEN; CD038 ANTIGEN; CD103 ANTIGEN; CD123 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLUTAMIC ACID; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOCORTIN 1; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ANTIGEN EXPRESSION; APLASIA; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANCER INFILTRATION; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HAIRY CELL LEUKEMIA VARIANT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MUTATION; NUCLEOLUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPLENIC MARGINAL ZONE LYMPHOMA; VALIDATION STUDY;

DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKEMIA, HAIRY CELL;

EID: 84875382111     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.11.021     Document Type: Article

References (39)

1. Sharpe R.W., Bethel K.J. Hairy cell leukemia: diagnostic pathology. Hematol Oncol Clin North Am 2006, 20:1023-1049.
2. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO classification of tumors of haematopoietic and lymphoid tissues 2008, IARC Press, Lyon. 4th ed.
3. Tallman M.S., Hakimian D., Variakojis D., Koslow D., Sisney G.A., Rademaker A.W., et al. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992, 80:2203-2209.
4. Jehn U., Bartl R., Dietzfelbinger H., Vehling-Kaiser U., Wolf-Hornung B., Hill W., et al. Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine. Ann Hematol 1999, 78:139-144.
5. Robak T., Blasinska-Morawiec M., Blonski J., Hellmann A., Halaburda K., Konopka L., et al. 2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol 1999, 62:49-56.
6. Tallman M.S., Hakimian D., Rademaker A.W., Zanzig C., Wollins E., Rose E., et al. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood 1996, 88:1954-1959.
7. Robbins D.H., Margulies I., Stetler-Stevenson M., Kreitman R.J. Hairy cell leukemia, a B-cell neoplasm that is particularly sensitive to the cytotoxic effect of anti-Tac(Fv)-PE38 (LMB-2). Clin Cancer Res 2000, 6:693-700.
8. Kreitman R.J., Wilson W.H., Bergeron K., Raggio M., Stetler-Stevenson M., FitzGerald D.J., et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med 2001, 345:241-247.
9. Kreitman R.J., Stetler-Stevenson M., Margulies I., Noel P., Fitzgerald D.J., Wilson W.H., et al. Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. J Clin Oncol 2009, 27:2983-2990.
10. Grever M.R. How I treat hairy cell leukemia. Blood 2010, 115:21-28.
11. Matutes E., Wotherspoon A., Catovsky D. The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003, 16:41-56.
12. Matutes E., Wotherspoon A., Brito-Babapulle V., Catovsky D. The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia 2001, 15:184-186.
13. de Totero D., Tazzari P.L., Lauria F., Raspadori D., di Celle P.F., Carbone A., et al. Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25). Blood 1993, 82:528-535.
14. Cessna M.H., Hartung L., Tripp S., Perkins S.L., Bahler D.W. Hairy cell leukemia variant: fact or fiction. Am J Clin Pathol 2005, 123:132-138.
15. Narat S., Gandla J., Dogan A., Mehta A. Successful treatment of hairy cell leukemia variant with rituximab. Leuk Lymphoma 2005, 46:1229-1232.
16. Sausville J.E., Salloum R.G., Sorbara L., Kingma D.W., Raffeld M., Kreitman R.J., et al. Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. Am J Clin Pathol 2003, 119:213-217.
17. Shao H., Yuan C.M., Xi L., Raffeld M., Morris J.C., Janik J.E., et al. Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma. Am J Clin Pathol 2010, 133:592-601.
18. Ravandi F., O'Brien S., Jorgensen J., Pierce S., Faderl S., Ferrajoli A., et al. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia. Blood 2011, 118:3818-3823.
19. Chen Y.H., Tallman M.S., Goolsby C., Peterson L. Immunophenotypic variations in hairy cell leukemia. Am J Clin Pathol 2006, 125:251-259.
20. Dong H.Y., Weisberger J., Liu Z., Tugulea S. Immunophenotypic analysis of CD103+B-lymphoproliferative disorders: hairy cell leukemia and its mimics. Am J Clin Pathol 2009, 131:586-595.
21. Venkataraman G., Aguhar C., Kreitman R.J., Yuan C.M., Stetler-Stevenson M. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders. Am J Clin Pathol 2011, 136:625-630.
22. Hassan I.B., Hagberg H., Sundstrom C. Immunophenotype of hairy-cell leukemia. Eur J Haematol 1990, 45:172-176.
23. Matutes E. Immunophenotyping and differential diagnosis of hairy cell leukemia. Hematol Oncol Clin North Am 2006, 20:1051-1063.
24. Borowitz M.J., Bray R., Gascoyne R., Melnick S., Parker J.W., Picker L., et al. U.S-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry 1997, 30:236-244.
25. Xi L., Arons E., Navarro W., Calvo K.R., Stetler-Stevenson M., Raffeld M., et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood 2012, 119:3330-3332.
26. Dunphy C.H., Petruska P.J. Atypical prolymphocytic variant of hairy-cell leukemia: case report and review of the literature. Am J Hematol 1996, 53:121-125.
27. Juliusson G., Lenkei R., Liliemark J. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood 1994, 83:3672-3681.
28. Ocio E.M., Hernandez J.M., Mateo G., Sanchez M.L., Gonzalez B., Vidriales B., et al. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma. Clin Lymphoma 2005, 5:241-245.
29. Hsieh Y.C., Chang S.T., Chuang S.S., Lu C.L., Tsao C.J., Lin C.N., et al. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review. Int J Clin Exp Pathol 2011, 4:183-189.
30. Kao H.W., Dunn P., Kuo M.C., Shih L.Y., Lin T.L., Wu J.H., et al. Classical hairy cell leukemia and its variant: a 17-year retrospective survey in Taiwan Chinese. Acta Haematol 2011, 126:186-193.
31. Del Giudice I., Matutes E., Morilla R., Morilla A., Owusu-Ankomah K., Rafiq F., et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica 2004, 89:303-308.
32. Munoz L., Nomdedeu J.F., Lopez O., Carnicer M.J., Bellido M., Aventin A., et al. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica 2001, 86:1261-1269.
33. Falini B., Tiacci E., Liso A., Basso K., Sabattini E., Pacini R., et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 2004, 363:1869-1870.
34. Tiacci E., Schiavoni G., Forconi F., Santi A., Trentin L., Ambrosetti A., et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 2012, 119:192-195.
35. Goodman G.R., Bethel K.J., Saven A. Hairy cell leukemia: an update. Curr Opin Hematol 2003, 10:258-266.
36. Jasionowski T.M., Hartung L., Greenwood J.H., Perkins S.L., Bahler D.W. Analysis of CD10+ hairy cell leukemia. Am J Clin Pathol 2003, 120:228-235.
37. Kaleem Z., White G., Vollmer R.T. Critical analysis and diagnostic usefulness of limited immunophenotyping of B-cell non-Hodgkin lymphomas by flow cytometry. Am J Clin Pathol 2001, 115:136-142.
38. Sokol L., Agosti S.J. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL). Am J Hematol 2004, 75:107-109.
39. Gine E., Bosch F., Villamor N., Rozman M., Colomer D., Lopez-Guillermo A., et al. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?. Leukemia 2002, 16:1454-1459.